Stayble Therapeutics changes Certified Adviser to Svensk Kapitalmarknadsgranskning AB
Stayble Therapeutics AB (”Stayble” or ”the Company”) hereby announces that the Company has entered into an agreement with Svensk Kapitalmarknadsgranskning AB (”SKMG”) regarding the service as Certified Adviser.SKMG will take over as Certified Adviser on 1 April 2022. Until then, Mangold Fondkommission AB will continue to act as a Certified Adviser for the Company.